Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.
about
Epigallocatechingallate attenuates myocardial injury in a mouse model of heart failure through TGF‑β1/Smad3 signaling pathway.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Epigallocatechingallate attenu ...... GF‑β1/Smad3 signaling pathway.
@en
Epigallocatechingallate attenu ...... GF‑β1/Smad3 signaling pathway.
@nl
type
label
Epigallocatechingallate attenu ...... GF‑β1/Smad3 signaling pathway.
@en
Epigallocatechingallate attenu ...... GF‑β1/Smad3 signaling pathway.
@nl
prefLabel
Epigallocatechingallate attenu ...... GF‑β1/Smad3 signaling pathway.
@en
Epigallocatechingallate attenu ...... GF‑β1/Smad3 signaling pathway.
@nl
P2093
P2860
P356
P1476
Epigallocatechingallate attenu ...... GF‑β1/Smad3 signaling pathway.
@en
P2093
Kai Feng Yu
Keyan Chen
Shi Li Liu
Tian Shi Wu
Xiao Yang Huang
Yijun Wang
P2860
P304
P356
10.3892/MMR.2018.8825
P577
2018-03-29T00:00:00Z